The store will not work correctly when cookies are disabled.
4-(5-((2-chloro-6-fluorophenyl)amino)-6-fluoro-1H-indazol-1-yl)-N-methylthiophene-2-carboxamide
ID: ALA4874573
PubChem CID: 156155399
Max Phase: Preclinical
Molecular Formula: C19H13ClF2N4OS
Molecular Weight: 418.86
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CNC(=O)c1cc(-n2ncc3cc(Nc4c(F)cccc4Cl)c(F)cc32)cs1
Standard InChI: InChI=1S/C19H13ClF2N4OS/c1-23-19(27)17-6-11(9-28-17)26-16-7-14(22)15(5-10(16)8-24-26)25-18-12(20)3-2-4-13(18)21/h2-9,25H,1H3,(H,23,27)
Standard InChI Key: QJBMKTXSJOENPI-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
1.5642 -23.7976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2761 -23.3849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8524 -23.3849 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5642 -24.6189 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0289 -23.7223 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.5798 -23.1109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1670 -22.3990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3636 -22.5691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4994 -21.6483 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6383 -20.3333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0876 -20.9407 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3818 -20.6647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2978 -21.4844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9653 -21.9671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7171 -21.6272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7975 -20.8040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1290 -20.3290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5457 -20.4662 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6252 -19.6487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3731 -19.3111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4529 -18.4944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7837 -18.0180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0368 -18.3600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9565 -19.1756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0406 -19.7924 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.3848 -22.1083 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.8524 -22.5636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2132 -19.5151 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
1 4 2 0
2 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 2 2 0
7 9 1 0
9 13 1 0
12 10 1 0
10 11 2 0
11 9 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
16 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
20 25 1 0
15 26 1 0
3 27 1 0
24 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 418.86 | Molecular Weight (Monoisotopic): 418.0467 | AlogP: 5.12 | #Rotatable Bonds: 4 |
Polar Surface Area: 58.95 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 14.00 | CX Basic pKa: 1.14 | CX LogP: 4.39 | CX LogD: 4.39 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.48 | Np Likeness Score: -1.91 |
References
1. Feng Y, Park H, Ryu JC, Yoon SO.. (2021) N-Aromatic-Substituted Indazole Derivatives as Brain-Penetrant and Orally Bioavailable JNK3 Inhibitors., 12 (10.0): [PMID:34676036] [10.1021/acsmedchemlett.1c00334] |